substance p has been researched along with Irritable Bowel Syndrome in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (50.00) | 29.6817 |
| 2010's | 12 (46.15) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Hou, YJ; Jiang, HL; Li, Y; Wang, K; Yao, JP; Zhou, SY | 1 |
| Dekker, J; Hamer, HM; Helyes, Z; Jonkers, DM; Keszthelyi, D; Ludidi, S; Masclee, AA; Szolcsányi, J; Troost, FJ; Vanhoutvin, S; Venema, K | 1 |
| Neri, M | 1 |
| Choi, HS; Jang, KS; Jun, DW; Lee, HL; Lee, KN; Lee, OY; Lee, SP; Sim, J; Sohn, W; Yoon, BC | 1 |
| Bian, ZX; Lin, ZS; Tsang, SW; Xiao, HT; Zhong, L | 1 |
| Kuang, HX; Wang, JW; Yin, Y; Zhao, WJ; Zhao, XY; Zhong, L | 1 |
| Anqi, W; Chunhui, B; Jie, S; Jimeng, Z; Weijun, T; Xiaojun, Y; Yin, S; Yuehua, C; Zhenzhong, L | 1 |
| Huang, D; Liang, LX; Liang, WJ; Luo, HS; Zhang, FC; Zhang, G | 1 |
| Lu, Y; Wang, SJ; Wang, Y; Zhang, YN; Zhao, HJ | 1 |
| Chen, H; Ding, M; Du, X; Fang, M; Fang, Y; Fu, X; Guo, F; Teng, W; Zhang, H | 1 |
| Barrett, KE; Camilleri, M; Sellin, JH | 1 |
| Ju, JM; Kong, M; Li, SL; Li, X; Lu, M; Luo, YH; Mao, Q; Shen, MQ; Shi, L; Wang, YY; Wang, ZG; Xu, JD; Zhou, SS | 1 |
| Lin, L; Lin, Z; Shi, R; Wang, M; Yan, Y; Zhang, H | 1 |
| Guo, J; Hu, XG; Meng, J; Shen, H; Xu, D; Yang, XB; Zhao, Y | 1 |
| Jiang, B; Liu, HR; Ma, XP; Tan, LY; Wu, HG; Yang, L; Yang, Y | 1 |
| Hu, R; Tang, F | 1 |
| Chai, JY; Guan, HQ; Han, XW; Wang, DS; Wang, J; Wang, YJ; Zhao, JR | 1 |
| Dong, WZ; Gong, YF; Li, ZS; Xu, GM; Yin, N; Zhu, AY; Zou, DW; Zou, XP | 1 |
| Duffy, RA | 1 |
| Fang, XC; Pan, GZ; Wang, LH | 1 |
| Bozymski, EM; Davies, MJ; Johnson, DA; Morteau, O; Palsson, OS; Sartor, RB; Turner, MJ; Whitehead, WE; Woosley, JT | 1 |
| Dong, WZ; Gong, YF; Li, ZS; Man, XH; Sun, ZX; Xu, GM; Yin, N; Zhu, AY; Zou, DW; Zou, XP | 1 |
| Crentsil, V | 1 |
| Bercik, P; Blennerhassett, P; Collins, SM; Huang, XX; Jackson, W; Mao, Y; Rochat, F; Verdú, EF; Verma-Gandhu, M; Wang, L | 1 |
| Peng, LH; Sun, G; Wang, WF; Yang, YS | 1 |
| Cui, YH; Jiang, B; Kou, ST; Liu, HR; Shi, DR; Shi, Z; Wu, HG; Zhou, EH | 1 |
3 review(s) available for substance p and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Traditional Chinese medicine formulas for irritable bowel syndrome: from ancient wisdoms to scientific understandings.
Topics: Cholecystokinin; Drugs, Chinese Herbal; Gastrointestinal Motility; Humans; Hypothalamo-Hypophyseal System; Intestines; Irritable Bowel Syndrome; Medicine, Chinese Traditional; Muscle, Smooth; Neurotransmitter Agents; Nitric Oxide; Nitric Oxide Synthase Type II; Pituitary-Adrenal System; Randomized Controlled Trials as Topic; Serotonin; Signal Transduction; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 2015 |
Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.
Topics: C-Reactive Protein; Chromogranins; Chronic Disease; Diarrhea; Feces; Gastrointestinal Motility; Humans; Inflammation; Intestinal Absorption; Intestinal Mucosa; Intestinal Secretions; Intestines; Irritable Bowel Syndrome; Lactoferrin; Leukocyte L1 Antigen Complex; Osmolar Concentration; Permeability; Prostaglandins; Serotonin; Substance P | 2017 |
Potential therapeutic targets for neurokinin-1 receptor antagonists.
Topics: Analgesics; Anti-Anxiety Agents; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antiemetics; Antineoplastic Agents; Antitussive Agents; Anxiety; Asthma; Clinical Trials as Topic; Cough; Cystitis; Depression; Drug Design; Humans; Inflammation; Irritable Bowel Syndrome; Neoplasms; Neurokinin-1 Receptor Antagonists; Pain; Substance P; Vomiting | 2004 |
1 trial(s) available for substance p and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Comparative effect of electroacupuncture and moxibustion on the expression of substance P and vasoactive intestinal peptide in patients with irritable bowel syndrome.
Topics: Adolescent; Adult; Aged; Electroacupuncture; Female; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Moxibustion; Substance P; Vasoactive Intestinal Peptide; Young Adult | 2015 |
22 other study(ies) available for substance p and Irritable Bowel Syndrome
| Article | Year |
|---|---|
[Study on the mechanism of electroacupuncture repairing intestinal barrier via regulating mast cell in rats with diarrhea-predominant irritable bowel syndrome].
Topics: Acupuncture Points; Animals; Diarrhea; Electroacupuncture; Female; Irritable Bowel Syndrome; Mast Cells; Occludin; Rats; Rats, Sprague-Dawley; Substance P; Tryptases; Visceral Pain | 2023 |
Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation?
Topics: Abdominal Pain; Colitis, Ulcerative; Colon, Sigmoid; Female; Humans; Intestinal Mucosa; Irritable Bowel Syndrome; Male; Somatostatin; Substance P; TRPV Cation Channels | 2013 |
Irritable bowel syndrome, inflammatory bowel disease and TRPV1: how to disentangle the bundle.
Topics: Abdominal Pain; Colitis, Ulcerative; Colon, Sigmoid; Female; Humans; Intestinal Mucosa; Irritable Bowel Syndrome; Male; Somatostatin; Substance P | 2013 |
Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Cell Count; Diarrhea; Female; Humans; Intestinal Mucosa; Irritable Bowel Syndrome; Male; Mast Cells; Middle Aged; Rectum; Sex Factors; Substance P; Vasoactive Intestinal Peptide; Young Adult | 2014 |
Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Colon; Defecation; Disease Models, Animal; Drugs, Chinese Herbal; Enteric Nervous System; Gastrointestinal Agents; Gastrointestinal Motility; Hypothalamus; Irritable Bowel Syndrome; Rats, Wistar; Serotonin; Signal Transduction; Substance P; Time Factors | 2015 |
Tryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome.
Topics: Abdominal Pain; Adult; Calcitonin Gene-Related Peptide; Case-Control Studies; Colon; Female; Humans; Irritable Bowel Syndrome; Male; Mast Cells; Middle Aged; Receptor, PAR-2; RNA, Messenger; Substance P; Tryptases; Vasoactive Intestinal Peptide | 2016 |
[Effect of Electroacupuncture Intervention on Constipation-predominant Irritable Bow l Syndrome and Colonic CGRP and SP Expression in Rats].
Topics: Animals; Calcitonin Gene-Related Peptide; Colon; Constipation; Electroacupuncture; Humans; Irritable Bowel Syndrome; Male; Rats; Rats, Wistar; Substance P | 2016 |
Expression and distribution of SP and its NK1 receptor in the brain-gut axis in neonatal maternally separated rat model with visceral hypersensitivity.
Topics: Animals; Colon; Hyperalgesia; Irritable Bowel Syndrome; Male; Maternal Deprivation; Muscle, Smooth; Myenteric Plexus; Organ Specificity; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Spinal Cord Dorsal Horn; Substance P | 2016 |
Chemical profiles and pharmacological activities of Chang-Kang-Fang, a multi-herb Chinese medicinal formula, for treating irritable bowel syndrome.
Topics: Acetic Acid; Animals; Calcitonin Gene-Related Peptide; Colon; Drugs, Chinese Herbal; Irritable Bowel Syndrome; Male; Mice; Phytochemicals; Rats, Sprague-Dawley; Serotonin; Substance P; Vasoactive Intestinal Peptide; Visceral Pain | 2017 |
Correlation of gut hormones with irritable bowel syndrome.
Topics: Adult; Aged; Cholecystokinin; Female; Gastrointestinal Hormones; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Neuropeptide Y; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 2008 |
The alleviating pain effect of aqueous extract from tong-xie-yao-fang, on experimental visceral hypersensitivity and its mechanism.
Topics: Abdominal Pain; Animals; Animals, Newborn; Brain; Colon; Corticotropin-Releasing Hormone; Disease Models, Animal; Drugs, Chinese Herbal; Female; Hyperalgesia; Irritable Bowel Syndrome; Maternal Deprivation; Pain Threshold; Rats; Rats, Sprague-Dawley; Serotonin; Substance P; Viscera | 2009 |
Effect of electro-acupuncture on substance P, its receptor and corticotropin-releasing hormone in rats with irritable bowel syndrome.
Topics: Animals; Colon; Corticotropin-Releasing Hormone; Disease Models, Animal; Electroacupuncture; Hypothalamus; Irritable Bowel Syndrome; Male; Mast Cells; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P | 2009 |
[Effect of Weichang Anwan on NO and 5-HT in blood serum, SP and MC in colon in IBS-D rats].
Topics: Animals; Colon; Disease Models, Animal; Drugs, Chinese Herbal; Female; Humans; Irritable Bowel Syndrome; Mast Cells; Nitric Oxide; Random Allocation; Rats; Rats, Wistar; Serotonin; Substance P | 2009 |
[Effects of eye-acupuncture therapy on serum and colonic SP and VIP contents in rats with irritable bowel syndrome].
Topics: Acupuncture Therapy; Animals; Colon; Disease Models, Animal; Eye; Humans; Irritable Bowel Syndrome; Male; Random Allocation; Rats; Substance P; Vasoactive Intestinal Peptide | 2010 |
[The changes of mucosal mast cells and substance P in patients with irritable bowel syndrome].
Topics: Adult; Aged; Female; Humans; Immunohistochemistry; Intestinal Mucosa; Irritable Bowel Syndrome; Male; Mast Cells; Middle Aged; Receptors, Neurokinin-1; Substance P | 2003 |
Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis.
Topics: Adult; Calcitonin Gene-Related Peptide; Colonic Diseases, Functional; Diarrhea; Dysentery, Bacillary; Female; Follow-Up Studies; Humans; Interleukin-1; Intestinal Mucosa; Irritable Bowel Syndrome; Male; Mast Cells; Nerve Fibers; Phosphopyruvate Hydratase; Risk Factors; Serotonin; Substance P | 2004 |
Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome.
Topics: Adult; Blotting, Western; Calcitonin Gene-Related Peptide; Dinoprostone; Female; Humans; Immunoassay; Interleukin-1; Intestinal Mucosa; Irritable Bowel Syndrome; Male; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 2004 |
Study of visceral hypersensitivity in irritable bowel syndrome.
Topics: Adult; Case-Control Studies; Defecation; Female; Humans; Intestinal Mucosa; Irritable Bowel Syndrome; Male; Mast Cells; Middle Aged; Pain Threshold; Perception; Pressure; Rectum; Substance P | 2004 |
Will corticosteroids and other anti-inflammatory agents be effective for diarrhea-predominant irritable bowel syndrome?
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Budesonide; Cyclooxygenase 2; Cytokines; Diarrhea; Dinoprostone; Disease Models, Animal; Humans; Irritable Bowel Syndrome; Lymphocyte Activation; Membrane Proteins; Mice; Models, Biological; Prostaglandin-Endoperoxide Synthases; RNA, Messenger; Substance P; T-Lymphocytes; Trichinella spiralis; Trichinellosis | 2005 |
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice.
Topics: Abdominal Pain; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Culture Media, Conditioned; Dexamethasone; Electromyography; Female; Hyperalgesia; Intestines; Irritable Bowel Syndrome; Mice; Mice, Inbred BALB C; Peroxidase; Physical Stimulation; Probiotics; Substance P | 2006 |
Alternation of substance P-containing neural pathways in a rat model of irritable bowel syndrome with rectal distension.
Topics: Animals; Biomarkers; Central Nervous System; Disease Models, Animal; Intestine, Large; Irritable Bowel Syndrome; Male; Neural Pathways; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Substance P | 2006 |
Regulatory mechanism of electroacupuncture in irritable bowel syndrome: preventing MC activation and decreasing SP VIP secretion.
Topics: Animals; Electroacupuncture; Immunohistochemistry; Indoles; Irritable Bowel Syndrome; Male; Mast Cells; Rats; Rats, Sprague-Dawley; Substance P; Vasoactive Intestinal Peptide | 2008 |